114 results in Exploration of Digestive Diseases
Most Downloaded
  • Latest
  • Most Viewed
  • Most Downloaded
  • Most Cited
Sort by :
Open Access Review
Hepatitis B virus: modes of transmission, immune pathogenesis, and research progress on therapeutic vaccines
Chunzheng Li ... Xianguang Yang
Published: October 14, 2024 Explor Dig Dis. 2024;3:443–458
This article belongs to the special issue Viral Hepatitis
27410 576 1
Open Access Review
Etiopathogenesis and pathophysiology of cholestasis
Maitane Asensio ... Jose J. G. Marin
Published: October 31, 2022 Explor Dig Dis. 2022;1:97–117
This article belongs to the special issue CHOLESTASIS
25729 539 4
Open Access Review
Drug-induced cholestasis: causative agents and challenges in diagnosis and management
Jose M. Pinazo-Bandera ... Miren García-Cortés
Published: September 18, 2023 Explor Dig Dis. 2023;2:202–222
This article belongs to the special issue CHOLESTASIS
44418 448 8
Open Access Review
Ascites in cirrhotic patients: a comprehensive review
Paul Carrier ... Laure Elkrief
Published: August 26, 2024 Explor Dig Dis. 2024;3:362–381
This article belongs to the special issue Cirrhosis and Its Complications
18546 334 4
Open Access Review
Fructose, a trigger of metabolic diseases?—a narrative review
Anja Baumann ... Ina Bergheim
Published: August 29, 2022 Explor Dig Dis. 2022;1:51–71
26393 260 4
Open Access Review
Zebrafish as a model for drug induced liver injury: state of the art and beyond
Gulcin Cakan-Akdogan ... Ozlen Konu
Published: April 26, 2023 Explor Dig Dis. 2023;2:44–55
This article belongs to the special issue Drug-induced Liver Injury: From Bench to Clinical Application
9564 197 6
Open Access Perspective
Transabdominal Gastro-Intestinal UltraSound (GIUS): a visual approach to intestinal pathology
Cristina Felicani ... Pietro Andreone
Published: July 05, 2024 Explor Dig Dis. 2024;3:241–261
10707 184 1
Open Access Review
MASLD vs. MAFLD. A narrative review
Amedeo Lonardo ... Mohammed Eslam
Published: August 14, 2025 Explor Dig Dis. 2025;4:100586
10828 162 5
Open Access Review
The central role of mitochondrial metabolism in hepatic steatosis
Sanda Win ... Filbert Win Min Aung
Published: February 29, 2024 Explor Dig Dis. 2024;3:42–68
This article belongs to the special issue Mitochondria and Lipid Signalling in Liver Diseases
13148 148 16
Open Access Review
Cholestasis associated to inborn errors in bile acid synthesis
Ricardo Espinosa-Escudero ... Maria J. Monte
Published: December 7, 2022 Explor Dig Dis. 2022;1:137–153
This article belongs to the special issue CHOLESTASIS
8122 134 2
Open Access Case Report
Diagnostic workup of suspected hereditary cholestasis in adults: a case report
Carola Dröge ... Verena Keitel
Published: April 21, 2023 Explor Dig Dis. 2023;2:34–43
This article belongs to the special issue CHOLESTASIS
5722 130 1
Open Access Review
An overview of pathogenesis of metabolic dysfunction-associated steatotic liver disease
Shahid Habib, Andrew Johnson
Published: November 11, 2024 Explor Dig Dis. 2024;3:459–473
6455 127 2
Open Access Review
Hepatocellular carcinoma surveillance after HBsAg seroclearance
Jimmy Che-To Lai ... Terry Cheuk-Fung Yip
Published: May 11, 2024 Explor Dig Dis. 2024;3:175–189
13409 124 0
Open Access Review
Mitochondrial ROS, a trigger for mitochondrial dysfunction and inflammasome activation and a therapeutic target in liver diseases
Hala Saeed Jaara, Sandra Torres
Published: December 10, 2024 Explor Dig Dis. 2024;3:474–503
This article belongs to the special issue Mitochondria and Lipid Signalling in Liver Diseases
15273 123 10
Open Access Review
Tumor immune microenvironment modulation by cholesterol in hepatocellular carcinoma
Alejandro Escobedo-Calvario ... María Concepción Gutiérrez-Ruíz
Published: July 29, 2022 Explor Dig Dis. 2022;1:21–39
8027 122 3
Open Access Review
Hepatitis B virus induced cirrhosis and hepatocarcinoma: pathogenesis and therapeutics
Juntian Yao ... Youhua Xie
Published: February 21, 2025 Explor Dig Dis. 2025;4:100565
This article belongs to the special issue Viral Hepatitis
9560 119 1
Open Access Original Article
Fructose induces metabolic reprogramming in liver cancer cells, promoting aggressiveness and chemotherapy resistance
Lisette Chávez-Rodríguez ... Luis E. Gomez-Quiroz
Published: April 20, 2025 Explor Dig Dis. 2025;4:100572
5152 111 1